0001062993-22-002741.txt : 20220204
0001062993-22-002741.hdr.sgml : 20220204
20220204200151
ACCESSION NUMBER: 0001062993-22-002741
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220202
FILED AS OF DATE: 20220204
DATE AS OF CHANGE: 20220204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Keefe Susan
CENTRAL INDEX KEY: 0001399594
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39894
FILM NUMBER: 22595218
MAIL ADDRESS:
STREET 1: C/O SERACARE LIFE SCIENCES, INC.
STREET 2: 375 WEST STREET
CITY: WEST BRIDGEWATER
STATE: MA
ZIP: 02379
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GreenLight Biosciences Holdings, PBC
CENTRAL INDEX KEY: 0001822691
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851914700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BOSTON AVENUE
STREET 2: SUITE 3100
CITY: MEDFORD
STATE: MA
ZIP: 02155
BUSINESS PHONE: (617) 616-8188
MAIL ADDRESS:
STREET 1: 200 BOSTON AVENUE
STREET 2: SUITE 3100
CITY: MEDFORD
STATE: MA
ZIP: 02155
FORMER COMPANY:
FORMER CONFORMED NAME: Environmental Impact Acquisition Corp
DATE OF NAME CHANGE: 20200826
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-02-02
0001822691
GreenLight Biosciences Holdings, PBC
GRNA
0001399594
Keefe Susan
C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC
200 BOSTON AVENUE, SUITE 3100
MEDFORD
MA
02155
0
1
0
0
CFO & Interim CAO
Stock Option (Right to Buy)
0.50
2022-02-02
4
A
0
488466
A
2029-05-10
Common Stock
488466
488466
D
Stock Option (Right to Buy)
0.98
2022-02-02
4
A
0
565760
A
2030-12-01
Common Stock
565760
565760
D
20% of the shares underlying the option vested or shall vest on June 3, 2020 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting July 3, 2020.
This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company.
25% of the shares underlying the option vested or shall vest on December 1, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting January 1, 2022.
/s/ David Kennedy, Attorney-in-fact
2022-02-04